PTGDS and breast cancer: Using PROGgeneV2 webtool, we found the high expression of cMYC, KLF4, and PTGES2 are associated with poor survival whereas the high expression of PTGDS is associated with better survival in patients with breast cancer (Fig. 6d-g).